These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29678586)

  • 1. MS-based conformation analysis of recombinant proteins in design, optimization and development of biopharmaceuticals.
    Goswami D; Zhang J; Bondarenko PV; Zhang Z
    Methods; 2018 Jul; 144():134-151. PubMed ID: 29678586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry.
    Huang RY; Chen G
    Anal Bioanal Chem; 2014 Oct; 406(26):6541-58. PubMed ID: 24948090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advancements in mass spectrometry for higher order structure characterization of protein therapeutics.
    Chen G; Tao L; Li Z
    Drug Discov Today; 2022 Jan; 27(1):196-206. PubMed ID: 34571276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products.
    Bobst CE; Kaltashov IA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1517-29. PubMed ID: 21542797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of stress-exposed granulocyte colony stimulating factor using ELISA and hydrogen/deuterium exchange mass spectrometry.
    Tsuchida D; Yamazaki K; Akashi S
    J Am Soc Mass Spectrom; 2014 Oct; 25(10):1747-54. PubMed ID: 25070584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of hydrogen/deuterium exchange or chemical cross-linking techniques with mass spectrometry: mapping of human 14-3-3ζ homodimer interface.
    Haladová K; Mrázek H; Ječmen T; Halada P; Man P; Novák P; Chmelík J; Obšil T; Šulc M
    J Struct Biol; 2012 Jul; 179(1):10-7. PubMed ID: 22580067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top-down mass spectrometry and hydrogen/deuterium exchange for comprehensive structural characterization of interferons: implications for biosimilars.
    Pan J; Borchers CH
    Proteomics; 2014 May; 14(10):1249-58. PubMed ID: 24574185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sucrose and benzyl alcohol on GCSF conformational dynamics revealed by hydrogen deuterium exchange mass spectrometry.
    Zhang J; Banks DD; He F; Treuheit MJ; Becker GW
    J Pharm Sci; 2015 May; 104(5):1592-600. PubMed ID: 25693946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Aggregation Propensity of a Human Fc-Fusion Protein Therapeutic by Hydrogen/Deuterium Exchange Mass Spectrometry.
    Huang RY; Iacob RE; Krystek SR; Jin M; Wei H; Tao L; Das TK; Tymiak AA; Engen JR; Chen G
    J Am Soc Mass Spectrom; 2017 May; 28(5):795-802. PubMed ID: 27527097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS.
    Engen JR
    Anal Chem; 2009 Oct; 81(19):7870-5. PubMed ID: 19788312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking Higher Order Protein Structure by Hydrogen-Deuterium Exchange Mass Spectrometry.
    Benhaim M; Lee KK; Guttman M
    Protein Pept Lett; 2019; 26(1):16-26. PubMed ID: 30543159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Binding Interface in a Noncovalent Size Variant of a Monoclonal Antibody Using Native Mass Spectrometry, Hydrogen-Deuterium Exchange Mass Spectrometry, and Computational Analysis.
    Yan Y; Wei H; Jusuf S; Krystek SR; Chen J; Chen G; Ludwig RT; Tao L; Das TK
    J Pharm Sci; 2017 Nov; 106(11):3222-3229. PubMed ID: 28634122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.
    Kaltashov IA; Bobst CE; Pawlowski J; Wang G
    J Pharm Biomed Anal; 2020 May; 184():113169. PubMed ID: 32092629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using hydrogen/deuterium exchange mass spectrometry to study conformational changes in granulocyte colony stimulating factor upon PEGylation.
    Wei H; Ahn J; Yu YQ; Tymiak A; Engen JR; Chen G
    J Am Soc Mass Spectrom; 2012 Mar; 23(3):498-504. PubMed ID: 22227798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review.
    Deng B; Lento C; Wilson DJ
    Anal Chim Acta; 2016 Oct; 940():8-20. PubMed ID: 27662755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing serpin conformational change using mass spectrometry and related methods.
    Tsutsui Y; Sarkar A; Wintrode PL
    Methods Enzymol; 2011; 501():325-50. PubMed ID: 22078541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating solution-phase protein structure and dynamics by hydrogen exchange mass spectrometry.
    Morgan CR; Engen JR
    Curr Protoc Protein Sci; 2009 Nov; Chapter 17():17.6.1-17.6.17. PubMed ID: 19937720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution MS for structural characterization of protein therapeutics: advances and future directions.
    Wei H; Tymiak AA; Chen G
    Bioanalysis; 2013 May; 5(10):1299-313. PubMed ID: 23721450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational analysis of g protein-coupled receptor signaling by hydrogen/deuterium exchange mass spectrometry.
    Li S; Lee SY; Chung KY
    Methods Enzymol; 2015; 557():261-78. PubMed ID: 25950969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Utilization of Hydrogen/Deuterium Exchange in Biopharmaceutical Industry].
    Coufalová D; Vojtěšek B; Hernychova L
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):59-63. PubMed ID: 27846722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.